Malnutrition due to bisphosphonate-related osteonecrosis of the jaw in a chronic dialysis patient: Case report

Renal Failure

Volumn 35, Issue 7, 2013, Pages 1008-1012

  Coskun Akar, Gulcan ^a   Efeoglu, Candan ^a   Alp, Alper ^b   Koseoglu, Kutsi ^c   Erol, Haluk ^b   Yenicerioglu, Yavuz ^b   Akar, Harun ^b  

^a EGE UNIVERSITY   (Turkey)

^b ADNAN MENDERES UNIVERSITY   (Turkey)

^c Medical School ^*  (Turkey)

Author keywords

Bisphosphonate; Dialysis patient; Malnutrition; Osteonecrosis

Indexed keywords

AMOXICILLIN; BICALUTAMIDE; BISPHOSPHONIC ACID DERIVATIVE; CHLORHEXIDINE; GONADORELIN AGONIST; ZOLEDRONIC ACID;

AGED; ANAMNESIS; ARTICLE; BISPHOSPHONATE RELATED OSTEONECROSIS OF THE JAW; CASE REPORT; DIALYSIS; ECHOGRAPHY; HUMAN; HYDRONEPHROSIS; JAW OSTEONECROSIS; JAW RADIOGRAPHY; MALE; MALNUTRITION; MOUTH EXAMINATION; MOUTH INFECTION; MOUTH PAIN; PRIORITY JOURNAL;

AGED, 80 AND OVER; AMOXICILLIN; ANTI-BACTERIAL AGENTS; BISPHOSPHONATE-ASSOCIATED OSTEONECROSIS OF THE JAW; BONE DENSITY CONSERVATION AGENTS; DIPHOSPHONATES; FATAL OUTCOME; HUMANS; MALE; MALNUTRITION; NUTRITIONAL STATUS; NUTRITIONAL SUPPORT; ORAL HYGIENE; PALLIATIVE CARE; RENAL DIALYSIS; TREATMENT OUTCOME;

EID: 84880252401     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2013.809005     Document Type: Article

References (39)

1. Pupim LB, Cuppari L, Ikizler TA. Nutrition and metabolism in kidney disease. Semin Nephrol. 2006;26:134-157.
2. Abraham G, Varsha P, Mathew M, Sairam VK, Gupta A. Malnutrition and nutritional therapy of chronic kidney disease in developing countries: the Asian perspective. Adv Ren Replace Ther. 2003;10:213-221.
3. Posner BM, Jette A, Smigelski C, Miller D, Mitchell P. Nutritional risk in New England elders. J Gerontol. 1994;49:123-132.
4. Sheiham A, Steele JG, Marcenes W, Finch S, Walls AW. The impact of oral health on stated ability to eat certain foods; findings from the National Diet and Nutrition Survey of older people in Great Britain. Geriodontology. 1999;16:11-20.
5. Carlos JP, Wolfe MD. Methodological and nutritional issues in assessing oral health of aged subjects. Am J Clin Nutr. 1989;50: 1210-1218.
6. Sheiham A, Steele JG, Marcenes W, et al. The relationship among dental status, nutrient intake, and nutritional status in older people. J Dent Res. 2001;80:408-413.
7. Takata Y, Ansai T, Matsumura K, et al. Relationship between tooth loss and electrocardiographic abnormalities in octogenarians. J Dent Res. 2001;80:1648-1652.
8. Takata Y, Ansai T, Awano S, et al. Activities of daily living and chewing ability in an 80-year-old population. Oral Dis. 2004;10: 365-368.
9. Ohba T, Takata Y, Ansai T, et al. Evaluation of calcified carotid artery atheromas detected by panoramic radiograph among octogenarians. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003;96:647-650.
10. Coleman RE. Metastatic bone disease: clinical features, pathophysiology and treatment strategies. Cancer Treat Rev. 2001;27: 165-176.
11. Hillner BE, Ingle JN, Chlebowski RT, et al. American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer. J Clin Oncol. 2003; 21:4042-4057.
12. Lacerna L, Hohneker J. Zoledronic acid for the treatment of bone metastases in patients with breast cancer and other solid tumors. Semin Oncol. 2003;30:150-160.
13. Diel IJ, Bergner R, Grotz KA. Adverse effects of bisphosphonates: current issues. J Support Oncol. 2007;5:475-582.
14. Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of jaws: a growing epidemic. J Oral Maxillofac Surg. 2003;61:1115-1117.
15. Wong P, Smith P, Rodger D. The use of intradialytic parenteral nutrition to treat malnutrition: a case study. CANNT J. 2003;13: 31-46.
16. Riella MC. Malnutrition in dialysis: malnourishment or uremic inflammatory response? Kidney Int. 2000;57:1211-1232.
17. Akar H, Akar GC, Carrero JJ, Stenvinkel P, Lindholm B. Systemic consequences of poor oral health in chronic kidney disease patients. Clin J Am Soc Nephrol. 2011;6:218-226.
18. Ruggiero SL, Dodson TB, Assael LA, et al. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate- related osteonecrosis of the jaws -2009 update. J Oral Maxillofac Surg. 2009;67:2-12.
19. Reid IR. Osteonecrosis of the jaw-who gets it and why? Bone 2009; 49:4-10.
20. Vieillard MH, Maes JM, Penel G, et al. Thirteen cases of jaw osteonecrosis in patients on bisphosphonate therapy. Joint Bone Spine. 2008;75:34-40.
21. Chiandussi S, Biosolto M, Dore F, Cavalli F, Cova MA, Di Lenarda R. Clinical and diagnostic imaging of bisphosphonate associated osteonecrosis of the jaws. Dentomaxillofac Radiol. 2006;35: 236-43.
22. Bisdas S, Chambron Pinho NC, Smolarz A, Sader R, Vogl TJ, Mack MG. Bisphosphonate-induced osteonecrosis of the jaws: CT and MRI spectrum of findings in 32 patients. Clin Radiol. 2008;63: 71-77.
23. Bedogni A, Blandamura S, Lokmic Z, et al. Bisphosphonateassociated jawbone osteonecrosis: a correlation between imaging techniques and histopathology. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008;105:358-364.
24. Wessel JH, Dodson TB, Zavras AI. Zoledronate, smoking, and obesity are strong risk factors for osteonecrosis of the jaw: a case -control study. J Oral Maxillofac Surg. 2008;66:625-631.
25. Baldi D, Izotti A, Bonica P, Pera P, Pulliero A. Degenerative periodontal-diseases, oral osteonecrosis: the role of gene -environment interactions. Mutat Res. 2009;667:118-131.
26. Kyrigidis A, Vahtsevenos K, Koloutsos G, et al. Bisphosphonate osteonecrosis risk factors: case control study of risk factors in breast cancer patients. J Clin Oncol. 2008;26:4634-4638.
27. Walter C, Al-Nawas B, Grötz KA, et al. Prevalance and risk factors of bisphosphonate-associated osteonecrosis of the jaw in prostate cancer patients with advanced disease treated with zoledronate. Eur Urol. 2008;54:1066-1072.
28. Ortega C, Montemurro F, Faggiuolo R, et al. Osteonecrosis of the jaw in prostate cancer patients with bone metastases treated with zoledronate: a retrospective analysis. Acta Oncol. 2007;46: 664-668.
29. Bamias A, Kastritis E, Bamia C, et al. Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors. J Clin Oncol. 2005;23:8580-8587.
30. Lazarovici TS, Mesilaty-Gross S, Vered I, et al. Serologic bone markers for predicting development of osteonecrosis of the jaw in patients receiving bisphosphonates. J Oral Maxillofac Surg. 2010; 68:2241-2247.
31. Tarassoff P, Csermak K. Avascular necrosis of the jaws: risk factors in metastatic cancer patients. J Oral Maxillofac Surg. 2003;61: 1238-1239.
32. Greenberg MS. Intravenous bisphosphonates and osteonecrosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004;98: 259-260.
33. Salesi N, Pistilli R, Marcelli V, et al. Bisphosphonates and oral cavity avascular bone necrosis: a review of twelve cases. Anticancer Res. 2006;26:3111-3115.
34. Mashiba T, Hirano T, Turner CH, Forwood MR, Johnston CC, Burr DB. Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib. J Bone Miner Res. 2001;15:613-620.
35. Walter C, Al-Nawas B, Grotz KA, et al. Prevalence and risk factors of bisphosphonate-associated osteonecrosis of the jaw in prostate cancer patients with advanced disease treated with zoledronate. Eur Urol. 2008;54:1066-1072.
36. Walter C, Grotz KA, Kunkel M, Al-Nawas B. Prevalence of bisphosphonate associated osteonecrosis of the jaw within the field of osteonecrosis. Support Care Cancer. 2007;15:197-202.
37. Ruggiero SL, Fantasia J, Carlson E. Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;102:433-441.
38. Park W, Lee SH, Park KR, Rho SH, Chung WY, Kim HJ. Characteristics of bisphosphonate-related osteonecrosis of the jaw after kidney transplantation. J Craniofac Surg. 2012;23:e510-e514.
39. Furuta M, Komiya-Nonaka M, Akifusa S, et al. Interrelationship of oral health status, swallowing function, nutritional status, and cognitive ability with activities of daily living in Japanese elderly people receiving home care services due to physical disabilities. Community Dent Oral Epidemiol. 2013;41:173-181.